Teladoc (TDOC) Reports Q4 Loss of $0.76, Slight Beat on Revenues; Offers FY18 EPS Outlook Below Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Teladoc (TDOC) Reports Expanded Collaboration with Microsoft (MSFT)
March 1, 2018 4:43 PM ESTTeladoc, Inc. (NYSE: TDOC) announced today its expanded collaboration with Microsoft (NYSE: MSFT). The organizations will be working together to advance the delivery of telehealth, with Teladocs platform running on the Microsoft Azure cloud platform. As a result of the joint go-to-market strategy, hospitals and health systems across the U.S. will have greater access to... More
Teladoc (TDOC) PT Lowered to $47 at Chardan Capital Markets, Keeps 'Buy'
February 28, 2018 7:29 AM ESTChardan Capital Markets lowered its price target on Teladoc (NYSE: TDOC) to $47.00 (from $48.00) while maintaining a Buy rating.
Analyst Steven Wardell commented, "After market close on Tue., TDOC reported earnings in-line with Consensus and maintained its preliminary 2018 revenue and adjusted EBITDA estimate... More
Teladoc (TDOC) PT Raised to $43 at Cowen; Sees Potential Upside to 2018 Guide
February 28, 2018 6:46 AM ESTCowen raised its price target on Teladoc (NYSE: TDOC) to $43.00 (from $39.00) while maintaining an Outperform rating following results.
Analyst Charles Rhyee sees potential upside to 2018 guidance.
... More